Research output per year
Research output per year
-
Simultaneous auto-transplant and CD19 CAR T-cell 2nd line therapy followed by CD20 × CD3 bispecific antibody for refractory Burkitt lymphoma, a case report
Stegemann, M., Macherndl-Spandl, S., Mairhofer, M., Kaltenbrunner, S., Buxhofer-Ausch, V., Clausen, J., Petzer, A. & Schmitt, C. A., Apr 2026, In: Leukemia and Lymphoma. 67, 5, p. 1147-1151 5 p.Research output: Contribution to journal › Article › peer-review
-
Author Correction: Virus-induced senescence is a driver and therapeutic target in COVID-19
Lee, S., Yu, Y., Trimpert, J., Benthani, F., Mairhofer, M., Richter-Pechanska, P., Wyler, E., Belenki, D., Kaltenbrunner, S., Pammer, M., Kausche, L., Firsching, T. C., Dietert, K., Schotsaert, M., Martínez-Romero, C., Singh, G., Kunz, S., Niemeyer, D., Ghanem, R. & Salzer, H. J. F. & 28 others, , Feb 2025, In: Nature. 638, 8052, p. E46 1 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Cell-based immune anticipation of the omicron variant in SARS-CoV-2 triple-vaccinated cancer patients
Mairhofer, M., Kausche, L., Kaltenbrunner, S., Pammer, M., Ghanem, R., Stegemann, M. & Schmitt, C. A., 21 Nov 2025, In: iScience. 28, 11, 113727.Research output: Contribution to journal › Article › peer-review
Open Access -
Chronic Stress Stimulates Protumor Macrophage Polarization to Propel Lung Cancer Progression
Liu, C., Du, H., Yu, G., Qi, J., Dong, H., Hu, R., Wang, F., Cui, B., Chen, W., Zhang, Q., Li, C., Gao, R., Schmitt, C. A., Deng, J., Yu, Y. & Du, J., 09 Apr 2025, (E-pub ahead of print) In: Cancer research. 85, 13, p. 2429-2447 19 p.Research output: Contribution to journal › Article
-
Comparing functional and genomic-based precision medicine in blood cancer patients
Kazianka, L., Pichler, A., Agreiter, C., Rohrbeck, J., Kornauth, C., Porpaczy, E., Sillaber, C., Sperr, W. R., Gleixner, K. V., Hauswirth, A., Jäger, U., Valent, P., Jonak, C., Porkert, S., Exner, R., Willenbacher, W., Wolf, D., Neumeister, P., Prochazka, K. & Deutsch, A. & 7 others, , Apr 2025, In: HemaSphere. 9, 4, e70129.Research output: Contribution to journal › Article › peer-review
Open Access
-
ABCSG61 Teodor
Stegemann, M. (Researcher), Kausche, L. E. (Researcher), Lichtenauer, N. (Researcher), Popp, H. D. (Researcher), Schwarz, H. K. (Researcher), Kühr, T. (Researcher), Schneeweiß, B. (Researcher), Ghanem, R. (Researcher), Schmitt, C. (Researcher), Preuß, C. (Researcher), Piringer, G. (Researcher), Stefan, A. (Researcher) & Kovacsova, J. (Researcher)
03.03.2026 → 02.09.2028
Project: Clinical studies › Clinical Study (Industry project)
-
Camelot-2
Popp, H. (Researcher), Lichtenauer, N. (Researcher), Kausche, L. E. (Researcher), Stegemann, M. (Researcher), Ghanem, R. (Researcher), Schneeweiß, B. (Researcher), Schmitt, C. (Researcher), Schwarz, H. K. (Researcher), Piringer, G. (Researcher), Kovacsova, J. (Researcher), Stefan, A. (Researcher) & Kühr, T. (Researcher)
01.12.2025 → 31.12.2029
Project: Clinical studies › Clinical Study (Industry project)
-
KRT-232-115
Lichtenauer, N. (Researcher), Stegemann, M. (Researcher), Stefan, A. (Researcher), Kausche, L. E. (Researcher), Piringer, G. (Researcher), Ghanem, R. (Researcher), Schmitt, C. (Researcher), Kovacsova, J. (Researcher), Popp, H. (Researcher), Schwarz, H. K. (Researcher), Schneeweiß, B. (Researcher) & Kühr, T. (Researcher)
01.09.2025 → 28.02.2029
Project: Clinical studies › Clinical Study (Industry project)
-
A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo- Controlled, Parallel-Arm Study Followed by an Open-Label Arm to Evaluate the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia (ARGX-113-2402)
Schmitt, C. (PI), Krivic, D. (Researcher), Lichtenauer, N. (Researcher), Kühr, T. (Researcher), Schneeweiß, B. (Researcher), Piringer, G. (Researcher), Popp, H. D. (Researcher), Krenosz, K. J. (Researcher), Ghanem, R. (Researcher), Stefan, A. (Researcher), Schwarz, H. K. (Researcher), Kovacsova, J. (Researcher), Kausche, L. E. (Researcher), Stegemann, M. (Researcher), Klein, K. (Researcher) & Trathnigg, N. (Researcher)
04.06.2025 → 31.05.2029
Project: Clinical studies › Clinical Study (Industry project)
-
Phase III randomized, open-label, international, multicenter study evaluating the efficacy and safety of mosunetuzumab plus lenalidomide in comparison to anti- CD20 monoclonal antibody plus chemotherapy in subjects with previously untreated FLIPI 2-5 follicular lymphoma (MorningLyte)
Schmitt, C. (PI), Krivic, D. (Researcher), Lichtenauer, N. (Researcher), Kühr, T. (Researcher), Schneeweiß, B. (Researcher), Piringer, G. (Researcher), Popp, H. D. (Researcher), Krenosz, K. J. (Researcher), Ghanem, R. (Researcher), Stefan, A. (Researcher), Schwarz, H. K. (Researcher), Kovacsova, J. (Researcher), Kausche, L. E. (Researcher), Stegemann, M. (Researcher), Klein, K. (Researcher) & Trathnigg, N. (Researcher)
02.06.2025 → 31.05.2029
Project: Clinical studies › Clinical Study (Industry project)
Activities
-
Lymphome
Schmitt, C. (Speaker)
18 Dec 2025Activity: Talk or presentation › Invited talk › science-to-science
-
Non-Hodgkin-Lymphome – Update Diagnostik und Therapie 2025
Schmitt, C. (Speaker)
29 Nov 2025Activity: Talk or presentation › Invited talk › science-to-science
-
Senescence-associated stemness – the driving principle of cancer cell persistence?
Schmitt, C. (Speaker)
25 Nov 2025Activity: Talk or presentation › Invited talk › science-to-science
-
Therapeutic opportunities for senescence in lymphoma and other cancers
Schmitt, C. (Speaker)
14 Nov 2025Activity: Talk or presentation › Invited talk › science-to-science
-
Lymphom: Unmet clinical need
Stegemann, M. (Speaker), Schmitt, C. (Contributor), Popp, H. (Speaker), Stefan, A. (Speaker), Rumpold, H. (Contributor), Clausen, J. (Speaker), Rotter, N. (Speaker), Strassl, I. (Speaker), Heine, A. (Speaker) & Heibl, S. (Speaker)
11 Nov 2025Activity: Talk or presentation › Invited talk › science-to-science